(30 days)
No
The summary describes a physical medical device (a catheter) and its intended use and performance testing. There is no mention of software, algorithms, image processing, or any terms related to AI or ML.
Yes
This device is a catheter designed for long-term vascular access for hemodialysis and apheresis treatments, which are therapeutic medical procedures.
No
This device is a long-term hemodialysis and apheresis catheter, which is used for treatment (vascular access), not for diagnosing conditions.
No
The device description clearly states it is a physical catheter made of polyurethane with a retention cuff and luer adapters, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "chronic hemodialysis and apheresis," which are medical procedures performed on a patient's body to treat conditions.
- Device Description: The description details a physical catheter designed for insertion into the vascular system.
- Anatomical Site: The device is placed in the femoral vein (or other vascular sites).
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, or tissue) in vitro (outside the body) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used to perform tests on samples taken from the body, while this device is a therapeutic device used to directly treat a patient.
N/A
Intended Use / Indications for Use
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is a symmetric tip dual lumen catheter designed for chronic hemodialysis and apheresis. It may be inserted percutaneously or by cut down. Catheters with greater than 37cm implant length are indicated for femoral placement.
Product codes (comma separated list FDA assigned to the subject device)
MSD
Device Description
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is a chronic, 15.5 French, dual lumen, radiopaque catheter made of polyurethane. It has a polyester retention cuff and two female luer adapters. The retention cuff promotes tissue ingrowth to anchor the catheter in the subcutaneous tunnel. The luer adapters are identical in color to indicate the reversibility of this catheter. This catheter features symmetrical side channels with a distal tip configuration designed to separate the intake flow from the output flow in both directions.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The results of performance testing, in conjunction with the substantial equivalence claims, effectively demonstrate the proposed device, Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes, is equivalent to the predicate device, Symetrex® Long Term Hemodialysis Catheter (K171618) & Symetrex® Long Term Hemodialysis Catheter with Sideholes (K173667). The performance testing was performed in accordance with the following standards: ISO 10555-1 (Air Leak, Catheter Leak, Extension-Hub, Extrusion-Hub, Gravity Flow), ISO 11607-1, ISO 11607-2 (Shipping and Shelf Life testing), and ISO 80369-7 (Gauging).
Biocompatibility was performed per ISO 10993-1 for a blood implant device with permanent exposure (> 30 days) on the final, finished device. The biological end points include:
- Hemocompatibility: ISO 10993-4, ASTM F 756-08
- Genotoxicity: ISO 10993-3
- Cytotoxicity: AAMI / ANSI / ISO 10993-5
- Irritation/Intracutaneous: ISO 10993-10
- Acute Systemic Toxicity: ISO 10993-11
- Implantation: ISO 10993-6, ASTM F763-04, ASTM F981-04
- Additional Testing: ISO 10993-18, ASTM D4128-06, ASTM D1971-11, ISO 10993-17
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5540 Blood access device and accessories.
(a)
Identification. A blood access device and accessories is a device intended to provide access to a patient's blood for hemodialysis or other chronic uses. When used in hemodialysis, it is part of an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and provides access to a patient's blood for hemodialysis. The device includes implanted blood access devices, nonimplanted blood access devices, and accessories for both the implanted and nonimplanted blood access devices.(1) The implanted blood access device is a prescription device and consists of various flexible or rigid tubes, such as catheters, or cannulae, which are surgically implanted in appropriate blood vessels, may come through the skin, and are intended to remain in the body for 30 days or more. This generic type of device includes various catheters, shunts, and connectors specifically designed to provide access to blood. Examples include single and double lumen catheters with cuff(s), fully subcutaneous port-catheter systems, and A-V shunt cannulae (with vessel tips). The implanted blood access device may also contain coatings or additives which may provide additional functionality to the device.
(2) The nonimplanted blood access device consists of various flexible or rigid tubes, such as catheters, cannulae or hollow needles, which are inserted into appropriate blood vessels or a vascular graft prosthesis (§§ 870.3450 and 870.3460), and are intended to remain in the body for less than 30 days. This generic type of device includes fistula needles, the single needle dialysis set (coaxial flow needle), and the single needle dialysis set (alternating flow needle).
(3) Accessories common to either type include the shunt adaptor, cannula clamp, shunt connector, shunt stabilizer, vessel dilator, disconnect forceps, shunt guard, crimp plier, tube plier, crimp ring, joint ring, fistula adaptor, and declotting tray (including contents).
(b)
Classification. (1) Class II (special controls) for the implanted blood access device. The special controls for this device are:(i) Components of the device that come into human contact must be demonstrated to be biocompatible. Material names and specific designation numbers must be provided.
(ii) Performance data must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:
(A) Pressure versus flow rates for both arterial and venous lumens, from the minimum flow rate to the maximum flow rate in 100 milliliter per minute increments, must be established. The fluid and its viscosity used during testing must be stated.
(B) Recirculation rates for both forward and reverse flow configurations must be established, along with the protocol used to perform the assay, which must be provided.
(C) Priming volumes must be established.
(D) Tensile testing of joints and materials must be conducted. The minimum acceptance criteria must be adequate for its intended use.
(E) Air leakage testing and liquid leakage testing must be conducted.
(F) Testing of the repeated clamping of the extensions of the catheter that simulates use over the life of the device must be conducted, and retested for leakage.
(G) Mechanical hemolysis testing must be conducted for new or altered device designs that affect the blood flow pattern.
(H) Chemical tolerance of the device to repeated exposure to commonly used disinfection agents must be established.
(iii) Performance data must demonstrate the sterility of the device.
(iv) Performance data must support the shelf life of the device for continued sterility, package integrity, and functionality over the requested shelf life that must include tensile, repeated clamping, and leakage testing.
(v) Labeling of implanted blood access devices for hemodialysis must include the following:
(A) Labeling must provide arterial and venous pressure versus flow rates, either in tabular or graphical format. The fluid and its viscosity used during testing must be stated.
(B) Labeling must specify the forward and reverse recirculation rates.
(C) Labeling must provide the arterial and venous priming volumes.
(D) Labeling must specify an expiration date.
(E) Labeling must identify any disinfecting agents that cannot be used to clean any components of the device.
(F) Any contraindicated disinfecting agents due to material incompatibility must be identified by printing a warning on the catheter. Alternatively, contraindicated disinfecting agents must be identified by a label affixed to the patient's medical record and with written instructions provided directly to the patient.
(G) Labeling must include a patient implant card.
(H) The labeling must contain comprehensive instructions for the following:
(
1 ) Preparation and insertion of the device, including recommended site of insertion, method of insertion, and a reference on the proper location for tip placement;(
2 ) Proper care and maintenance of the device and device exit site;(
3 ) Removal of the device;(
4 ) Anticoagulation;(
5 ) Management of obstruction and thrombus formation; and(
6 ) Qualifications for clinical providers performing the insertion, maintenance, and removal of the devices.(vi) In addition to Special Controls in paragraphs (b)(1)(i) through (v) of this section, implanted blood access devices that include subcutaneous ports must include the following:
(A) Labeling must include the recommended type of needle for access as well as detailed instructions for care and maintenance of the port, subcutaneous pocket, and skin overlying the port.
(B) Performance testing must include results on repeated use of the ports that simulates use over the intended life of the device.
(C) Clinical performance testing must demonstrate safe and effective use and capture any adverse events observed during clinical use.
(vii) In addition to Special Controls in paragraphs (b)(1)(i) through (v) of this section, implanted blood access devices with coatings or additives must include the following:
(A) A description and material characterization of the coating or additive material, the purpose of the coating or additive, duration of effectiveness, and how and where the coating is applied.
(B) An identification in the labeling of any coatings or additives and a summary of the results of performance testing for any coating or material with special characteristics, such as decreased thrombus formation or antimicrobial properties.
(C) A Warning Statement in the labeling for potential allergic reactions including anaphylaxis if the coating or additive contains known allergens.
(D) Performance data must demonstrate efficacy of the coating or additive and the duration of effectiveness.
(viii) The following must be included for A-V shunt cannulae (with vessel tips):
(A) The device must comply with Special Controls in paragraphs (b)(1)(i) through (v) of this section with the exception of paragraphs (b)(1)(ii)(B), (b)(1)(ii)(C), (b)(1)(v)(B), and (b)(1)(v)(C), which do not apply.
(B) Labeling must include Warning Statements to address the potential for vascular access steal syndrome, arterial stenosis, arterial thrombosis, and hemorrhage including exsanguination given that the device accesses the arterial circulation.
(C) Clinical performance testing must demonstrate safe and effective use and capture any adverse events observed during clinical use.
(2) Class II (performance standards) for the nonimplanted blood access device.
(3) Class II (performance standards) for accessories for both the implanted and the nonimplanted blood access devices not listed in paragraph (b)(4) of this section.
(4) Class I for the cannula clamp, disconnect forceps, crimp plier, tube plier, crimp ring, and joint ring, accessories for both the implanted and nonimplanted blood access device. The devices subject to this paragraph (b)(4) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 3, 2020
Medical Components, Inc. (Dba. Medcomp®) Courtney Nix Regulatory Affairs Director, North America and Europe 1499 Delp Drive Harleysville, PA 19438
Re: K202176
Trade/Device Name: Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes Regulation Number: 21 CFR§ 876.5540 Regulation Name: Blood Access Device and Accessories Regulatory Class: II Product Code: MSD Dated: August 3, 2020 Received: August 4, 2020
Dear Courtney Nix:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Carolyn Y. Neuland, Ph.D. Assistant Director DHT3A: Division of Renal, Gastrointestinal, Obesity and Transplant Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202176
Device Name
Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes
Indications for Use (Describe)
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is a symmetric tip dual lumen catheter designed for chronic hemodialysis and apheresis. It may be inserted percutaneously or by cut down. Catheters with greater than 37cm implant length are indicated for femoral placement.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image shows the logo for medCOMP. The logo features a red geometric shape above the text "medCOMP". The "med" portion of the text is in red, while the "COMP" portion is in gray.
Medical Components, Inc. 1499 Delp Drive Harleysville, PA 19438, U.S.A. P: 215.256.4201 F: 215.256.1787 www.medcompnet.com
| Section 6 | 510(k) SUMMARY | Special 510K |
|---|---|---|
| A. Submitter Information | K202176 | |
| Submitter Name: | Medical Components Inc. | |
| (dba Medcomp®) | ||
| 1499 Delp Drive | ||
| Harleysville, PA 19438 | ||
| Tel (215) 256-4201 X 2285 | ||
| Fax (215) 256-9191 | ||
| Registration Number: | 2518902 | |
| Contact Person: | Courtney Nix | |
| Regulatory Affairs Director, North America | ||
| and Europe | ||
| Date of Preparation: | 07/31/2020 | |
| B. Subject Device | ||
| Trade Name: | Symetrex® Long Term Hemodialysis Catheter & | |
| Symetrex® Long Term Hemodialysis Catheter with | ||
| Sideholes | ||
| Device: | Catheter, Hemodialysis, Implanted | |
| Product Code: | MSD | |
| Regulation Description: | Blood access device and accessories | |
| Regulation Number: | 21 CFR 876.5540 | |
| Class: | II (Special Controls) | |
| Regulation Medical | ||
| Specialty and Review | ||
| Panel: | Gastroenterology/Urology | |
| C. Predicate Device | ||
| 510(k) Number: | K171618 & K173667 | |
| 510(k) Holder: | Medcomp® | |
| Trade Name: | Symetrex® Long Term Hemodialysis Catheter & | |
| Symetrex® Long Term Hemodialysis Catheter with | ||
| Sideholes |
4
Image /page/4/Picture/1 description: The image contains the logo for medCOMP. The logo consists of a red geometric shape that resembles a stylized letter "C" or a partially enclosed square. Below the geometric shape, the word "med" is written in red, followed by "COMP" in black. The font appears to be sans-serif, and the overall design is clean and modern.
Medical Components 1499 Dolo Drive larleysville, PA 19438, U.S. P: 215 256.4201 215.256.1787 ww.medcomonet.com
| Device: | Catheter, Hemodialysis, Implanted |
|---|---|
| Product Code: | MSD |
| Regulation Description: | Blood access device and accessories |
| Regulation Number: | 21 CFR 876.5540 |
| Class: | II (Special Controls) |
| Regulation Medical | |
| Specialty and Review | |
| Panel: | Gastroenterology/Urology |
D. Device Description:
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is a chronic, 15.5 French, dual lumen, radiopaque catheter made of polyurethane. It has a polyester retention cuff and two female luer adapters. The retention cuff promotes tissue ingrowth to anchor the catheter in the subcutaneous tunnel. The luer adapters are identical in color to indicate the reversibility of this catheter. This catheter features symmetrical side channels with a distal tip configuration designed to separate the intake flow from the output flow in both directions.
E. Indications For Use:
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is a symmetric tip dual lumen catheter designed for chronic hemodialysis and apheresis. It may be inserted percutaneously or by cut down. Catheters with greater than 37cm implant length are indicated for femoral placement.
F. Intended Use:
Long term, greater than 30 days, vascular access for Hemodialysis and Apheresis treatments.
G. Comparison to Predicate Device(s):
Table 6.1: 510(k) Summary Design Comparison Matrix
| Attribute | Subject Device
Symetrex® Long Term
Hemodialysis Catheter &
Symetrex® Long Term
Hemodialysis Catheter
with Sideholes | Predicate Device
Symetrex® Long Term
Hemodialysis Catheter
(K171618) & Symetrex®
Long Term Hemodialysis
Catheter with Sideholes
(K173667) |
|--------------|------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Prescription | Prescription Use | Prescription Use |
5
Image /page/5/Picture/1 description: The image shows the logo for medCOMP. The logo consists of a red geometric shape that resembles a stylized letter "M" or an abstract building. Below the shape, the word "medCOMP" is written in a combination of red and gray letters. The "med" portion is in red, while the "COMP" portion is in gray.
Medical Components. 1499 Deln Drive Harleysville, PA 19438, U.S. 215 256 4201 215 256 1787
vww.medcompnet.com
| Indications for Use | The Symetrex® Long Term
Hemodialysis Catheter with
Sideholes is a symmetric tip
dual lumen catheter
designed for chronic
hemodialysis and aphersis. It
may be inserted
percutaneously of by cut
down. Catheters with greater
than 37cm implant length are
indicated for femoral
placement. | |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
| Catheter O.D. | 15.5Fr | 15.5Fr |
| Lengths | 19cm-42cm | 19cm-42cm |
| Duration of Use | Long Term | Long Term |
| Sterilization Method | EO | EO |
| Number of Lumens | 2 | 2 |
| Patient Population | Adult | Adult |
H. Bench/Performance Data/ Non-Clinical Testing:
The results of performance testing, in conjunction with the substantial equivalence claims, effectively demonstrate the proposed device, Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes, is equivalent to the predicate device, Symetrex® Long Term Hemodialysis Catheter (K171618) & Symetrex® Long Term Hemodialysis Catheter with Sideholes (K173667). The performance testing was performed in accordance with the following standards:
| Table 6.2: Applicable Standards and Performance Testing | |||||
|---|---|---|---|---|---|
| -- | -- | -- | -- | --------------------------------------------------------- | -- |
| Standard | Standard Title | Revision/ Date | Performance
Testing |
|-------------|----------------------------------------------------------------------------------------------------------------------------------|------------------------------|------------------------------------------------------------------------------|
| ISO 10555-1 | Intravascular
catheters --
sterile and single-
use
intravascular
catheters -- part
1: general
requirements. | Second Edition
2013-06-15 | Air Leak, Catheter
Leak, Extension-Hub,
Extrusion-Hub,
Gravity Flow |
| ISO 11607-1 | Packaging for
terminally
sterilized medical
devices - part
1: requirements
for materials,
sterile barrier | First Edition
2006-04-15 | Shipping and Shelf
Life testing |
6
Image /page/6/Picture/1 description: The image shows the MedComp logo. The logo consists of a red geometric shape above the word "medCOMP". The geometric shape is made up of lines and curves, and it is red in color. The word "medCOMP" is written in a combination of red and gray letters.
Medical Components, I 1499 Deln Drive Harleysville, PA 19438, U.S. 215 256 420 w medcompnet cor
| ISO 11607-2 | systems and
packaging
systems
[including:
amendment 1
(2014)].
Packaging for
terminally
sterilized medical
devices - part
2: validation
requirements for
forming, sealing
and assembly
processes
[including:
amendment 1
(2014)]. | First Edition
2006-04-15 | Shipping and Shelf
Life testing |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|------------------------------------|
| ISO 80369-7 | ISO 80369-7
First edition
2016-10-15
Small-bore
connectors for
liquids and gases
in healthcare
applications -
Part 7:
Connectors for
intravascular or
hypodermic
applications | First Edition
2016-10-15 | Gauging |
1. Biocompatibility
Biocompatibility was performed for the Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes per ISO 10993-1 for a blood implant device with permanent exposure (i.e. > 30 days). Biocompatibility was performed on the final, finished device. The biological end points include:
- Hemocompatibility: ●
- ISO 10993-4 Biological Evaluation Of Medical Devices Part 4: Selection Of O Tests For Interaction With Blood
- ASTM F 756-08, Standard Practice for Assessment of Hemolytic Properties o of Materials, 2008
- Genotoxicity:
- o ISO 10993-3, Biological Evaluation of Medical Devices Part 3: Tests for Genotoxicity, Carcinogenicity and Reproductive Toxicity.
7
- Cytotoxicity:
- AAMI / ANSI / ISO 10993-5: Biological evaluation of medical devices part 5: o tests for in vitro cytotoxicity.
- Irritation/Intracutaneous: 0
- ISO 10993-10 Biological Evaluation of Medical Devices Part 10: Tests for O Irritation and Skin Sensitization.
- Acute Systemic Toxicity: ●
- ISO 10993-11 Biological Evaluation of Medical Devices Part 11: Tests for O Systemic Toxicity
- Implantation: ●
- ISO 10993-6 Biological Evaluation of Medical Devices Part 6: Tests for o Local Effects after Implantation.
- ASTM F763-04 Standard Practice For Short-Term Screening of Implant O Materials.
- ASTM F981-04 Standard Practice For Assessment of Compatibility of O Biomaterials for Surgical Implants With Respect To Effect of Materials on Muscle and Bone.
- Additional Testing: 0
- ISO 10993-18 Biological Evaluation of Medical Devices Part 18: Chemical O Characterization of Materials
- ASTM D4128-06 Standard Guide for Identification of Quantitation of Organic O Compounds in Water by Combined Gas Chromatography and Electron Impact Mass Spectrometry
- ASTM D1971-11 Standard Practices for Digestion of Water Samples for O Determination of Metals by Flame Atomic Absorption, Graphite Furnace Atomic Absorption, Plasma Emission Spectroscopy, or Plasma Mass Spectroscopy
- ISO 10993-17 Biological Evaluation of Medical Devices Part 17: O Establishment of Allowable Limits for Leachable Substances
J. Cybersecurity and Wireless Information
The Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes is not an electrical device. There is no cybersecurity and wireless information.
K. Summary of Substantial Equivalence
In conclusion, the proposed device, Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes, is considered substantially equivalent to the predicate device, Symetrex® Long Term Hemodialysis (K171618) & Symetrex® Long Term Hemodialysis Catheter with Sideholes (K173667), as demonstrated through non-clinical testing performed.
Medcomp®: Medcomp®: Symetrex® Long Term Hemodialysis Catheter & Symetrex® Long Term Hemodialysis Catheter with Sideholes Section 6: 510(k) Site Summary
•
•
Medical Components, Inc
1499 Deln Drive rleysville, PA 19438, U.S. P: 215.256.4201 F: 215,256.1787 www.medcomonet.com